Sanders; Steven W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sanders; Steven W..The latest application filed is for "compositions and methods for transdermal oxybutynin therapy".

Company Profile

0.10.13

Sanders; Steven W. - Salt Lake City UT
Sanders; Steven W. - Ft. Lauderdale FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for unoccluded transdermal oxybutynin therapy Grant 10,272,061 - Ebert , et al.	2019-04-30
Compositions And Methods For Transdermal Oxybutynin Therapy App 20170095438 - Ebert; Charles D. ; et al.	2017-04-06
Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy Grant 8,241,662 - Ebert , et al. August 14, 2	2012-08-14
Compositions and Methods for Transdermal Oxybutynin Therapy App 20090018190 - Ebert; Charles D. ; et al.	2009-01-15
Adhesive preparation comprising sufentanil and methods of using same App 20070202156 - Saeki; Yuji ; et al.	2007-08-30
Compositions and methods for transdermal oxybutynin therapy App 20070148195 - Ebert; Charles D. ; et al.	2007-06-28
Compositions and methods for transdermal oxybutynin therapy Grant 7,179,483 - Ebert , et al. February 20, 2	2007-02-20
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Grant 7,087,241 - Sanders , et al. August 8, 2	2006-08-08
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Grant 7,081,250 - Sanders , et al. July 25, 2	2006-07-25
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Grant 7,081,252 - Sanders , et al. July 25, 2	2006-07-25
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Grant 7,081,251 - Sanders , et al. July 25, 2	2006-07-25
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Grant 7,081,249 - Sanders , et al. July 25, 2	2006-07-25
Compositions and methods for transdermal oxybutynin therapy Grant 7,029,694 - Ebert , et al. April 18, 2	2006-04-18
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy App 20060078613 - Sanders; Steven W. ; et al.	2006-04-13
Compositions and methods for transdermal oxybutynin therapy App 20050226898 - Ebert, Charles D. ; et al.	2005-10-13
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy App 20050048107 - Sanders, Steven W. ; et al.	2005-03-03
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy App 20050048106 - Sanders, Steven W. ; et al.	2005-03-03
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy App 20040259954 - Sanders, Steven W. ; et al.	2004-12-23
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy App 20040120996 - Sanders, Steven W. ; et al.	2004-06-24
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy Grant 6,743,441 - Sanders , et al. June 1, 2	2004-06-01
Compositions and methods for transdermal oxybutynin therapy App 20030147926 - Ebert, Charles D. ; et al.	2003-08-07
Compositions and methods for transdermal oxybutynin therapy App 20030124177 - Ebert, Charles D. ; et al.	2003-07-03
Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy App 20020147236 - Sanders, Steven W. ; et al.	2002-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.